Matsuda, N., Wang, X., Lim, B., Krishnamurthy, S., Alvarez, R. H., Willey, J. S., . . . Ueno, N. T. (2018). Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer. JAMA Oncol.
Citação norma ChicagoMatsuda, Naoko, et al. "Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer." JAMA Oncol 2018.
Citação norma MLAMatsuda, Naoko, et al. "Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer." JAMA Oncol 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.